Shopping Cart 0
Cart Subtotal
USD 0

Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater. Tandem offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Tandem Diabetes Care Inc Company Overview

Tandem Diabetes Care Inc Company Snapshot

Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview

Tandem Diabetes Care Inc-Pipeline Analysis Overview

Tandem Diabetes Care Inc-Key Facts

Tandem Diabetes Care Inc-Major Products and Services

Tandem Diabetes Care Inc Pipeline Products by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc Pipeline Products Overview

AutoSoft XC

AutoSoft XC Product Overview

Connected Health Mobile App

Connected Health Mobile App Product Overview

Next Generation Gswim

Next Generation Gswim Product Overview

t:connect Mobile

t:connect Mobile Product Overview

t:slim X2 Control-IQ System-Pediatrics

t:slim X2 Control-IQ System-Pediatrics Product Overview

t:slim X2 Control-IQ System-Pediatrics Clinical Trial

t:slim X2 Pump With Dexcom G6 and HCL

t:slim X2 Pump With Dexcom G6 and HCL Product Overview

t:slim X2 Pump With Dexcom G6 and HCL Clinical Trial

t:sport

t:sport Product Overview

Tandem Diabetes Care Inc-Key Competitors

Tandem Diabetes Care Inc-Key Employees

Tandem Diabetes Care Inc-Locations And Subsidiaries

Head Office

Recent Developments

Tandem Diabetes Care Inc, Recent Developments

Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology

Nov 04, 2019: Tandem Diabetes Care announces third quarter 2019 financial results and updated 2019 financial guidance

Nov 01, 2019: 2019 Beyond Type Run team to race the TCS New York City Marathon using Basal-IQ Technology from Tandem Diabetes Care

Oct 30, 2019: Tandem Diabetes Care presents positive real-world data from pediatric users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference

Oct 17, 2019: Artificial pancreas system shows promise in clinical trial

Oct 16, 2019: Tandem Diabetes Care Announces NEJM Publication of landmark study demonstrating increased time-in-range with the t:slim X2 Insulin Pump with Control-IQ Technology

Sep 18, 2019: andem Diabetes Care announces publication of Real-world Basal-IQ predictive low glucose suspend technology data in Diabetes Technology and Therapeutics Journal

Aug 01, 2019: Tandem Diabetes Care announces second quarter 2019 financial results and updated 2019 financial guidance

Aug 01, 2019: Tandem Diabetes Care announces no-cost software updates for t:slim X2 Insulin Pump customers in the United States

Jun 09, 2019: Tandem Diabetes Care reports positive results from two studies of the t:slim X2 Insulin Pump With Control-IQ Technology

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Tandem Diabetes Care Inc Pipeline Products by Equipment Type

Tandem Diabetes Care Inc Pipeline Products by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview

Tandem Diabetes Care Inc Pipeline Products by Equipment Type

Tandem Diabetes Care Inc Pipeline Products by Indication

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc, Key Facts

Tandem Diabetes Care Inc, Major Products and Services

Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage

Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc Ongoing Clinical Trials Summary

AutoSoft XC-Product Status

AutoSoft XC-Product Description

Connected Health Mobile App-Product Status

Connected Health Mobile App-Product Description

Next Generation Gswim-Product Status

Next Generation Gswim-Product Description

t:connect Mobile-Product Status

t:connect Mobile-Product Description

t:slim X2 Control-IQ System-Pediatrics-Product Status

t:slim X2 Control-IQ System-Pediatrics-Product Description

t:slim X2 Control-IQ System-Pediatrics-The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas in Pediatrics: A Study of t:Slim X2 with Control-IQ Technology

t:slim X2 Pump With Dexcom G6 and HCL-Product Status

t:slim X2 Pump With Dexcom G6 and HCL-Product Description

t:slim X2 Pump With Dexcom G6 and HCL-A Randomized Cross-over Clinical Trial to Assess the Efficacy of Closed-loop Control (CLC) and Predictive Low-glucose Suspend (PLGS) Compared with Sensor-augmented Pump Therapy (SAP) Among Older Adults with Type 1 Diabetes

t:slim X2 Pump With Dexcom G6 and HCL-An Extension Study of t:Slim X2 with Control-IQ Technology

t:slim X2 Pump With Dexcom G6 and HCL-Assessment of the Efficacy of Closed-loop Insulin Therapy (Artificial Pancreas) on the Control of Type 1 Diabetes in Prepubertal Child in Free-life: Comparison Between Nocturnal and 24-hour Use on 18 Weeks, Followed by an Extension on 18 Weeks

t:sport-Product Status

t:sport-Product Description

Tandem Diabetes Care Inc, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Tandem Diabetes Care Inc, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Insulet Corp

IRadimed Corp

Stryker Corp

Adherium Ltd

Company Profile

Company Profile Title

Summary

Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater. Tandem offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Tandem Diabetes Care Inc Company Overview

Tandem Diabetes Care Inc Company Snapshot

Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview

Tandem Diabetes Care Inc-Pipeline Analysis Overview

Tandem Diabetes Care Inc-Key Facts

Tandem Diabetes Care Inc-Major Products and Services

Tandem Diabetes Care Inc Pipeline Products by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc Pipeline Products Overview

AutoSoft XC

AutoSoft XC Product Overview

Connected Health Mobile App

Connected Health Mobile App Product Overview

Next Generation Gswim

Next Generation Gswim Product Overview

t:connect Mobile

t:connect Mobile Product Overview

t:slim X2 Control-IQ System-Pediatrics

t:slim X2 Control-IQ System-Pediatrics Product Overview

t:slim X2 Control-IQ System-Pediatrics Clinical Trial

t:slim X2 Pump With Dexcom G6 and HCL

t:slim X2 Pump With Dexcom G6 and HCL Product Overview

t:slim X2 Pump With Dexcom G6 and HCL Clinical Trial

t:sport

t:sport Product Overview

Tandem Diabetes Care Inc-Key Competitors

Tandem Diabetes Care Inc-Key Employees

Tandem Diabetes Care Inc-Locations And Subsidiaries

Head Office

Recent Developments

Tandem Diabetes Care Inc, Recent Developments

Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology

Nov 04, 2019: Tandem Diabetes Care announces third quarter 2019 financial results and updated 2019 financial guidance

Nov 01, 2019: 2019 Beyond Type Run team to race the TCS New York City Marathon using Basal-IQ Technology from Tandem Diabetes Care

Oct 30, 2019: Tandem Diabetes Care presents positive real-world data from pediatric users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference

Oct 17, 2019: Artificial pancreas system shows promise in clinical trial

Oct 16, 2019: Tandem Diabetes Care Announces NEJM Publication of landmark study demonstrating increased time-in-range with the t:slim X2 Insulin Pump with Control-IQ Technology

Sep 18, 2019: andem Diabetes Care announces publication of Real-world Basal-IQ predictive low glucose suspend technology data in Diabetes Technology and Therapeutics Journal

Aug 01, 2019: Tandem Diabetes Care announces second quarter 2019 financial results and updated 2019 financial guidance

Aug 01, 2019: Tandem Diabetes Care announces no-cost software updates for t:slim X2 Insulin Pump customers in the United States

Jun 09, 2019: Tandem Diabetes Care reports positive results from two studies of the t:slim X2 Insulin Pump With Control-IQ Technology

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Tandem Diabetes Care Inc Pipeline Products by Equipment Type

Tandem Diabetes Care Inc Pipeline Products by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview

Tandem Diabetes Care Inc Pipeline Products by Equipment Type

Tandem Diabetes Care Inc Pipeline Products by Indication

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc, Key Facts

Tandem Diabetes Care Inc, Major Products and Services

Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage

Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage

Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status

Tandem Diabetes Care Inc Ongoing Clinical Trials Summary

AutoSoft XC-Product Status

AutoSoft XC-Product Description

Connected Health Mobile App-Product Status

Connected Health Mobile App-Product Description

Next Generation Gswim-Product Status

Next Generation Gswim-Product Description

t:connect Mobile-Product Status

t:connect Mobile-Product Description

t:slim X2 Control-IQ System-Pediatrics-Product Status

t:slim X2 Control-IQ System-Pediatrics-Product Description

t:slim X2 Control-IQ System-Pediatrics-The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas in Pediatrics: A Study of t:Slim X2 with Control-IQ Technology

t:slim X2 Pump With Dexcom G6 and HCL-Product Status

t:slim X2 Pump With Dexcom G6 and HCL-Product Description

t:slim X2 Pump With Dexcom G6 and HCL-A Randomized Cross-over Clinical Trial to Assess the Efficacy of Closed-loop Control (CLC) and Predictive Low-glucose Suspend (PLGS) Compared with Sensor-augmented Pump Therapy (SAP) Among Older Adults with Type 1 Diabetes

t:slim X2 Pump With Dexcom G6 and HCL-An Extension Study of t:Slim X2 with Control-IQ Technology

t:slim X2 Pump With Dexcom G6 and HCL-Assessment of the Efficacy of Closed-loop Insulin Therapy (Artificial Pancreas) on the Control of Type 1 Diabetes in Prepubertal Child in Free-life: Comparison Between Nocturnal and 24-hour Use on 18 Weeks, Followed by an Extension on 18 Weeks

t:sport-Product Status

t:sport-Product Description

Tandem Diabetes Care Inc, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Tandem Diabetes Care Inc, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Insulet Corp

IRadimed Corp

Stryker Corp

Adherium Ltd